Aethon Therapeutics

New York, United States

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness.

$30.0M raised

Jan 2023

Series A

Biotechnology Health Care Product Research

Top Investors

Apple Tree Partners NYU Langone Health

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aethon Therapeutics

How much funding has Aethon Therapeutics raised?

Aethon Therapeutics has raised $30.0M in total funding. The most recent round was Series A. The last funding was announced in January 2023.

Who are Aethon Therapeutics's investors?

Aethon Therapeutics's investors include Apple Tree Partners, NYU Langone Health.

Where is Aethon Therapeutics headquartered?

Aethon Therapeutics is headquartered in New York, United States.

What does Aethon Therapeutics do?

Aethon Therapeutics treats cancer by combining immunotherapy and targeted treatment to increase its effectiveness.

What stage is Aethon Therapeutics at?

Aethon Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 9, 2023.

MLA

"Aethon Therapeutics — Funding & Investors." VCBacked, January 9, 2023, https://www.vcbacked.co/company/aethon-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2023). Aethon Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/aethon-therapeutics

Wikipedia (cite web)

{{cite web |title=Aethon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aethon-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 9, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K